HK Stock MarketDetailed Quotes

633 (00633)

Watchlist
  • 0.000
  • 0.0000.00%
Market Closed Apr 24 09:30 CST
0Market Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

633 (00633) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
(FY)Dec 31, 2018
(Q6)Jun 30, 2018
(FY)Dec 31, 2017
Turnover
-51.20%1.55B
-27.03%5.45B
40.85%3.18B
48.14%7.47B
13.26%2.26B
196.27%5.04B
175.84%1.99B
-32.34%1.7B
-39.30%723M
-18.08%2.52B
Operating income
-51.20%1.55B
-27.03%5.45B
40.85%3.18B
48.14%7.47B
13.26%2.26B
196.27%5.04B
175.84%1.99B
-32.34%1.7B
-39.30%723M
-18.08%2.52B
Cost of sales
51.10%-1.51B
26.97%-5.37B
-37.66%-3.1B
-48.23%-7.35B
-13.42%-2.25B
-211.12%-4.96B
-230.11%-1.98B
23.96%-1.59B
41.67%-600.6M
15.62%-2.1B
Operating expenses
51.10%-1.51B
26.97%-5.37B
-37.66%-3.1B
-48.23%-7.35B
-13.42%-2.25B
-211.12%-4.96B
-230.11%-1.98B
23.96%-1.59B
41.67%-600.6M
15.62%-2.1B
Gross profit
-54.92%38.81M
-30.36%83.79M
745.25%86.09M
42.53%120.33M
-13.06%10.19M
-22.13%84.42M
-90.43%11.72M
-74.18%108.42M
-24.14%122.41M
-28.47%419.9M
Selling expenses
56.34%-1.22M
51.79%-4.98M
-173.65%-2.79M
-65.38%-10.34M
50.22%-1.02M
4.01%-6.25M
25.58%-2.05M
26.86%-6.51M
50.63%-2.76M
45.39%-8.9M
Administrative expenses
34.00%-55.12M
-74.60%-106.13M
-186.48%-83.5M
83.51%-60.79M
45.52%-29.15M
-146.52%-368.65M
6.26%-53.5M
24.13%-149.55M
25.56%-57.07M
32.10%-197.11M
Research and development expenses
-609.99%-98.53M
-579.15%-184.55M
-205.15%-13.88M
81.39%-27.17M
17.70%-4.55M
-1,450.45%-145.98M
23.39%-5.53M
-1.72%-9.42M
-15.52%-7.21M
71.98%-9.26M
Revaluation surplus
----
----
----
----
----
----
---5.8M
----
----
----
-Changes in the fair value of financial assets
----
----
----
----
----
----
---5.8M
----
----
----
Impairment and provision
----
79.98%-121.97M
----
52.38%-609.31M
----
-1,357.49%-1.28B
-945.68%-201.88M
---87.79M
---19.31M
----
-Other impairment is provision
----
79.98%-121.97M
----
52.38%-609.31M
----
-1,357.49%-1.28B
-945.68%-201.88M
---87.79M
---19.31M
----
Special items of operating profit
-340.21%-120.1M
2,300.08%426.88M
219.40%50M
95.02%-19.4M
4.08%15.65M
-987.96%-389.29M
-75.06%15.04M
-52.42%43.84M
27.93%60.31M
886.66%92.14M
Adjustment items of operating profit
----
--1K
----
----
----
----
----
----
----
----
Operating profit
-757.66%-236.15M
115.34%93.05M
504.41%35.91M
71.18%-606.68M
96.33%-8.88M
-1,984.31%-2.11B
-351.11%-242M
-134.04%-101.01M
-19.69%96.37M
15.60%296.77M
Financing income
239.64%3.2M
189.59%5.12M
562.68%941K
-5.66%1.77M
-99.85%142K
-93.60%1.87M
757.16%92.19M
0.79%29.3M
-67.74%10.76M
-56.13%29.06M
Financing cost
90.76%-13.44M
-23.33%-308.09M
24.64%-145.39M
54.94%-249.82M
46.43%-192.93M
-153.34%-554.43M
-469.54%-360.17M
-12.51%-218.85M
42.54%-63.24M
6.31%-194.51M
Share of profits of associates
----
----
----
----
----
-341.04%-1.71M
---982K
-60.81%709K
----
1,037.31%1.81M
Special items of earning before tax
----
----
----
----
----
----
----
----
----
--6.97M
Earning before tax
-127.00%-246.4M
75.44%-209.93M
46.18%-108.54M
67.86%-854.73M
60.53%-201.67M
-817.55%-2.66B
-1,264.32%-510.96M
-306.89%-289.86M
1.40%43.89M
21.66%140.1M
Tax
148.61%4.28M
255.33%13.85M
-30.24%-8.81M
-508.32%-8.92M
-108.09%-6.77M
78.55%-1.47M
81.47%-3.25M
44.55%-6.83M
-49.11%-17.54M
67.22%-12.32M
After-tax profit from continuing operations
-106.31%-242.11M
77.30%-196.08M
43.70%-117.35M
67.55%-863.65M
59.47%-208.43M
-796.92%-2.66B
-2,052.07%-514.21M
-332.19%-296.69M
-16.41%26.34M
64.73%127.78M
After-tax profit from non-continuing business
----
----
----
----
----
----
----
-465.25%-381.42M
---1.21M
-31.96%104.43M
Special items of earning after tax
----
----
----
----
----
----
----
-465.25%-381.42M
---1.21M
-31.96%104.43M
Earning after tax
-106.31%-242.11M
77.30%-196.08M
43.70%-117.35M
67.55%-863.65M
59.47%-208.43M
-292.43%-2.66B
-2,146.05%-514.21M
-392.03%-678.11M
-20.25%25.13M
0.50%232.21M
Minority profit
-30.63%-435K
-79.85%-714K
---333K
79.63%-397K
----
---1.95M
----
----
----
58.61%3.43M
Shareholders should account for profits from continuing business
----
----
----
----
----
----
----
---296.69M
----
----
Shareholders should account for profits from non-continuing business
----
----
----
----
----
----
----
---381.42M
----
----
Profit attributable to shareholders
-106.53%-241.68M
77.37%-195.36M
43.86%-117.02M
67.54%-863.25M
59.47%-208.43M
-292.14%-2.66B
-2,146.05%-514.21M
-396.40%-678.11M
-9.19%25.13M
-0.05%228.78M
Basic earnings per share
-100.00%-0.1
77.21%-0.085
44.44%-0.05
70.11%-0.373
65.38%-0.09
-257.59%-1.248
-2,100.00%-0.26
-398.29%-0.349
-7.14%0.013
-4.88%0.117
Diluted earnings per share
-100.00%-0.1
77.21%-0.085
44.44%-0.05
70.11%-0.373
65.38%-0.09
-257.59%-1.248
-2,100.00%-0.26
-398.29%-0.349
-7.14%0.013
-2.50%0.117
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
--
Unaudited opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
--
--
--
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019(FY)Dec 31, 2018(Q6)Jun 30, 2018(FY)Dec 31, 2017
Turnover -51.20%1.55B-27.03%5.45B40.85%3.18B48.14%7.47B13.26%2.26B196.27%5.04B175.84%1.99B-32.34%1.7B-39.30%723M-18.08%2.52B
Operating income -51.20%1.55B-27.03%5.45B40.85%3.18B48.14%7.47B13.26%2.26B196.27%5.04B175.84%1.99B-32.34%1.7B-39.30%723M-18.08%2.52B
Cost of sales 51.10%-1.51B26.97%-5.37B-37.66%-3.1B-48.23%-7.35B-13.42%-2.25B-211.12%-4.96B-230.11%-1.98B23.96%-1.59B41.67%-600.6M15.62%-2.1B
Operating expenses 51.10%-1.51B26.97%-5.37B-37.66%-3.1B-48.23%-7.35B-13.42%-2.25B-211.12%-4.96B-230.11%-1.98B23.96%-1.59B41.67%-600.6M15.62%-2.1B
Gross profit -54.92%38.81M-30.36%83.79M745.25%86.09M42.53%120.33M-13.06%10.19M-22.13%84.42M-90.43%11.72M-74.18%108.42M-24.14%122.41M-28.47%419.9M
Selling expenses 56.34%-1.22M51.79%-4.98M-173.65%-2.79M-65.38%-10.34M50.22%-1.02M4.01%-6.25M25.58%-2.05M26.86%-6.51M50.63%-2.76M45.39%-8.9M
Administrative expenses 34.00%-55.12M-74.60%-106.13M-186.48%-83.5M83.51%-60.79M45.52%-29.15M-146.52%-368.65M6.26%-53.5M24.13%-149.55M25.56%-57.07M32.10%-197.11M
Research and development expenses -609.99%-98.53M-579.15%-184.55M-205.15%-13.88M81.39%-27.17M17.70%-4.55M-1,450.45%-145.98M23.39%-5.53M-1.72%-9.42M-15.52%-7.21M71.98%-9.26M
Revaluation surplus ---------------------------5.8M------------
-Changes in the fair value of financial assets ---------------------------5.8M------------
Impairment and provision ----79.98%-121.97M----52.38%-609.31M-----1,357.49%-1.28B-945.68%-201.88M---87.79M---19.31M----
-Other impairment is provision ----79.98%-121.97M----52.38%-609.31M-----1,357.49%-1.28B-945.68%-201.88M---87.79M---19.31M----
Special items of operating profit -340.21%-120.1M2,300.08%426.88M219.40%50M95.02%-19.4M4.08%15.65M-987.96%-389.29M-75.06%15.04M-52.42%43.84M27.93%60.31M886.66%92.14M
Adjustment items of operating profit ------1K--------------------------------
Operating profit -757.66%-236.15M115.34%93.05M504.41%35.91M71.18%-606.68M96.33%-8.88M-1,984.31%-2.11B-351.11%-242M-134.04%-101.01M-19.69%96.37M15.60%296.77M
Financing income 239.64%3.2M189.59%5.12M562.68%941K-5.66%1.77M-99.85%142K-93.60%1.87M757.16%92.19M0.79%29.3M-67.74%10.76M-56.13%29.06M
Financing cost 90.76%-13.44M-23.33%-308.09M24.64%-145.39M54.94%-249.82M46.43%-192.93M-153.34%-554.43M-469.54%-360.17M-12.51%-218.85M42.54%-63.24M6.31%-194.51M
Share of profits of associates ---------------------341.04%-1.71M---982K-60.81%709K----1,037.31%1.81M
Special items of earning before tax --------------------------------------6.97M
Earning before tax -127.00%-246.4M75.44%-209.93M46.18%-108.54M67.86%-854.73M60.53%-201.67M-817.55%-2.66B-1,264.32%-510.96M-306.89%-289.86M1.40%43.89M21.66%140.1M
Tax 148.61%4.28M255.33%13.85M-30.24%-8.81M-508.32%-8.92M-108.09%-6.77M78.55%-1.47M81.47%-3.25M44.55%-6.83M-49.11%-17.54M67.22%-12.32M
After-tax profit from continuing operations -106.31%-242.11M77.30%-196.08M43.70%-117.35M67.55%-863.65M59.47%-208.43M-796.92%-2.66B-2,052.07%-514.21M-332.19%-296.69M-16.41%26.34M64.73%127.78M
After-tax profit from non-continuing business -----------------------------465.25%-381.42M---1.21M-31.96%104.43M
Special items of earning after tax -----------------------------465.25%-381.42M---1.21M-31.96%104.43M
Earning after tax -106.31%-242.11M77.30%-196.08M43.70%-117.35M67.55%-863.65M59.47%-208.43M-292.43%-2.66B-2,146.05%-514.21M-392.03%-678.11M-20.25%25.13M0.50%232.21M
Minority profit -30.63%-435K-79.85%-714K---333K79.63%-397K-------1.95M------------58.61%3.43M
Shareholders should account for profits from continuing business -------------------------------296.69M--------
Shareholders should account for profits from non-continuing business -------------------------------381.42M--------
Profit attributable to shareholders -106.53%-241.68M77.37%-195.36M43.86%-117.02M67.54%-863.25M59.47%-208.43M-292.14%-2.66B-2,146.05%-514.21M-396.40%-678.11M-9.19%25.13M-0.05%228.78M
Basic earnings per share -100.00%-0.177.21%-0.08544.44%-0.0570.11%-0.37365.38%-0.09-257.59%-1.248-2,100.00%-0.26-398.29%-0.349-7.14%0.013-4.88%0.117
Diluted earnings per share -100.00%-0.177.21%-0.08544.44%-0.0570.11%-0.37365.38%-0.09-257.59%-1.248-2,100.00%-0.26-398.29%-0.349-7.14%0.013-2.50%0.117
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----------Unaudited opinion--Unqualified Opinion--Unqualified Opinion
Auditor ----------National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.69%
Sample Name
Sample Code
 +0.44%
Sample Name
Sample Code
 -2.38%
4
CHINA OILFIELD
02883
-3.34%
5
CNOOC
00883
-5.23%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.01%
Sample Name
Sample Code
 +22.47%
Sample Name
Sample Code
 +20.53%
4
Rockchip Electronics
603893
+19.38%
5
Ucloud Technology Co., Ltd
688158
+18.90%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -